Posts by Sandra Ansanay-Alex
BioAlps Networking Day
The BioAlps Networking Day attracts each year about 350 key players from the Swiss Health Valley🇨🇭 region: representatives from academia, startups, government, and media gather to share the latest trends in Life Sciences and connect with each other. BioAlps Networking Day 2026 BioAlps flagship event will take place on 19 November 2026 at Beaulieu Lausanne.…
Read MoreBIND – BioInnovation Day
BIND – BioInnovation Day is an exclusive technology showcase and networking event that brings together Life Sciences innovators and investors. The BIND is an event that was initially organised by UNITEC, the Technology transfer office of the University of Geneva (UNIGE) and The Hospital of Geneva, and the PACTT, the Technology transfer office…
Read MoreRepronovo raises $65 million in series A
ReproNovo, a Vaud-Based company dedicated to developing innovative treatments for reproductive medicine and women’s health, announced the successful closing of a $65 million Series A financing round. The round was led by Jeito Capital, co-led by AXA IM Alts and founding investor M Ventures, with strong syndicate support from Ysios Capital and ALSA Ventures. The…
Read MoreMeet the HBA – Morges
The event Meet the HBA (Healthcare Business Women Association) in Morges is taking place on 28 April 2026. Interested in getting to know more about the HBA and meeting some of our members? Join HBA members, leaders, and others committed to gender parity in an informal setting to learn more about HBA happenings locally and…
Read MoreDayOne Accelerator
Apply before 31 May 2026 for DayOne Accelerator, a programme dedicated to healthtech projects. The DayOne Accelerator is looking for early-stage healthtech and techbio startups wanting to collaborate with pharma and bring impactful solutions to market. This programme is designed for Startups from Pre-Seed to Series A (<$10M raised) working on tech solutions that accelerate pharma…
Read MoreOneDoc Merges With Medicosearch
OneDoc, the leading Swiss platform for booking online medical appointments, has acquired Medicosearch. This transaction is another important step in the development of the Geneva-based company, consolidating its position as the leading player in digital healthcare in Switzerland, with over 13,000 registered healthcare professionals and more than 350,000 consultations booked online each month. The new…
Read MoreDePoly raised $23 Million
The Valais-based scale-up and HES-SO Valais-Wallis spinoff prepares to demonstrate industrial-scale implementation of its revolutionary technology that transforms plastic waste into virgin-quality raw materials without fossil fuels. Every year, millions of tons of PET and polyester waste end up in landfills or are incinerated, yet sustainable recycling solutions remain limited. DePoly – the leading…
Read MoreNestlé Opens A New R&D Centre Dedicated To Biotech And Deeptech In Orbe
Nestlé announced the strengthening of its R&D expertise in biotechnology and the creation of a new centre for deep tech, to boost its innovation pipeline and increase efficiency in research, innovation and operations. The investments will be unlocked by a leaner R&D organization, more agile ways of working, a focused project portfolio and the redeployment of existing R&D…
Read MoreAnnaida Technologies SA closes oversubscribed Pre-Series A
Annaida Technologies, a Vaud-based start-up company bringing magnetic resonance to the scale of cells, announces the successful closing of its oversubscribed Pre-Series A funding round. The round, led by HEMEX, saw the participation from existing investors including Zürcher Kantonalbank (ZKB), Excellis, EFI Lake Geneva Ventures, and members of Club degli Investitori through Simon…
Read MoreAdoram Therapeutics Secures CHF 1 Million Grant from Innosuisse
Adoram Therapeutics has secured a CHF 1.05 million grant from Innosuisse to propel its groundbreaking anti-inflammatory programme, aiming to develop safer and more effective therapies. Adoram Therapeutics is a University of Geneva (UNIGE) spinoff specializing in allosteric modulators for cancer immunotherapy and inflammatory conditions. The Innosuisse Grant will allow the research will be…
Read More